Francis Medical获FDA批准使用水蒸气消融术治疗前列腺癌。
Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer
生命科学资讯
生物技术与制药领域的最新动态
Bleecker大爆炸：Formation Bio通过6.05亿美元Lynk交易成立新子公司
Bleecker's big bang: Formation Bio unveils new subsidiary with $605M Lynk deal
赛诺菲与葛兰素史克签署临床前协议，共同研发新型自身免疫与癌症抗体。
Sanofi, GSK ink preclinical pacts in quest for new autoimmune and cancer antibodies
投资者抢购生物科技史上最大规模增发日股票
Investors buy up stocks in biggest follow-on offering day in biotech history
苹果树公司申请破产，寻求俄罗斯亿万富翁支持者注资。
Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backer
美国抗生素公司获加速批准生产阿莫西林
USAntibiotics scores sped-up approval for amoxicillin
沃特世公司(WAT)因并购潜力获沃尔夫研究上调评级 - GuruFocus
Waters Corporation (WAT) Upgraded by Wolfe Research Amid Merger Potential - GuruFocus
沃特世公司(WAT)因合并潜力获Wolfe Research上调评级 - GuruFocus
Waters Corporation (WAT) Upgraded by Wolfe Research Amid Merger Potential - GuruFocus
2025年12月10日诊所动态
In the clinic for Dec. 10, 2025
BioWorld Insider播客：探索更优、更持久的阿片类药物过量解决方案
The BioWorld Insider podcast: Finding a better, longer-lasting fix in opioid overdose
D3 Bio完成1.08亿美元B轮融资，推进KRAS G12C进入三期临床试验。
D3 Bio raises $108M series B to move KRAS G12C into phase III
2025年12月10日人事任命与晋升公告
Appointments and advancements for Dec. 10, 2025
2025年12月10日融资动态
Financings for Dec. 10, 2025
2025年12月10日其他值得关注的新闻
Other news to note for Dec. 10, 2025
2025年12月10日监管动态
Regulatory actions for Dec. 10, 2025
Adare Pharma关闭费城工厂并裁员逾百人。
Adare Pharma shutters Philadelphia site and lays off over 100 staffers
FDA批准首个国家优先审评券计划药物
FDA approves first drug in National Priority Voucher program
Cytiva与Fidabio携手拓展蛋白质研究分析能力 - 合同制药
Cytiva, Fidabio Partner to Expand Analytical Capabilities for Protein Research - Contract Pharma
FDA首次批准非营利组织基因疗法。
In a first, FDA approves a gene therapy from a nonprofit
多模态AI生成虚拟人群用于肿瘤微环境建模
Multimodal AI generates virtual population for tumor microenvironment modeling